No Data
No Data
Insider Buying: Fusen Pharmaceutical Executive Chairman Bought CN¥908k Of Shares
Investors who take an interest in Fusen Pharmaceutical Company Limited (HKG:1652) should definitely note that the Executive Chairman, Changcheng Cao, recently paid HK$0.87 per share to buy HK$908k wor
福森藥業:年報2023
Fuson Pharmaceuticals (01652.HK) was granted by Full Bliss Holdings Limited to increase its common share holdings by 650,000 shares worth approximately HK$575,300
On April 25, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on April 25, Full Bliss Holdings Limited increased its share holdings of $Fussen Pharmaceuticals (01652.HK) by $650,000 at an average price of HK$0.885 per share on April 19, worth approximately HK$575,300. After the increase in holdings, Full Bliss Holdings Limited's latest shareholding was 205 million shares, and the good position ratio increased from 27.30% to 27.39%. This transaction involves other related parties: Cao Changcheng and Quan Xiufeng. pictures
Fuson Pharmaceuticals (01652.HK) was granted by Full Bliss Holdings Limited to increase its common share holdings by 1.041 million shares, worth approximately HK$907,500
On April 25, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on April 25, Full Bliss Holdings Limited increased its share holdings of $Fussen Pharmaceuticals (01652.HK) by $1.041 million at an average price of HK$0.8718 per share on April 22, worth about HK$907,500. After the increase in holdings, Full Bliss Holdings Limited's latest shareholding was 206 million shares, and the good position ratio rose from 27.39% to 27.53%. This transaction involves other related parties: Cao Changcheng and Quan Xiufeng
Fuson Pharmaceuticals (01652.HK) was granted by One Victory Investments Limited to increase its common stock holdings by 240,000 shares worth approximately HK$212,000
On April 24, it was reported that, according to documents disclosed by the Hong Kong Stock Exchange on April 24, One Victory Investments Limited increased its share holdings of $Fussen Pharmaceuticals (01652.HK) by $240,000 at an average price of HK$0.8833 per share on April 18, worth approximately HK$212,000. After the increase in holdings, One Victory Investments Limited's latest shareholding was 155 million shares, and the good position ratio increased from 20.59% to 20.62%. This transaction involves other related parties: Quan Xiufeng
Forson Pharmaceutical (01652.HK): Application for marketing license for “Compound Potassium Hydrogen Phosphate Injection” was accepted
Gelonghui, April 23 | Forson Pharmaceutical (01652.HK) announced that the compound potassium hydrogen phosphate injection developed by Jiaheng (Zhuhai Hengqin) Pharmaceutical Technology Co., Ltd., a wholly-owned subsidiary of the Group, has submitted a marketing application to the China National Drug Administration and has been accepted for the treatment of the following diseases: as a phosphorus supplement in complete parenteral nutritional therapy; it can also be used for hypophosphatemia caused by certain diseases. Phosphorus is involved in sugar phosphorylation in sugar metabolism, making up phospholipids in membrane components, and is an important component of RNA, DNA, and many coenzymes in cells. Phosphorus is also involved in energy storage, conversion, and body fluid buffering functions
No Data